Liver cancer imaging: The need for accurate detection of intrahepatic disease spread

Journal of Computer Assisted Tomography

Volumn 23, Issue SUPPL., 1999, Pages

  Solbiati, Luigi ^a   Cova, Luca ^a   Ierace, Tiziana ^a   Marelli, Piera ^a   Dellanoce, Marina ^a  

^a BUSTO ARSIZIO HOSPITAL   (Italy)

Author keywords

Ablative therapies; Computed tomography; Liver neoplasms; Radiofrequency; Ultrasound; US contrast media

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; DISEASES; MAGNETIC RESONANCE; MEDICAL IMAGING; ULTRASONIC APPLICATIONS;

ABLATIVE THERAPY; CANCER IMAGING; COMPUTED TOMOGRAPHY; CONTRAST MEDIUM; DISEASE SPREAD; LESION DETECTION; LIVER CANCERS; LIVER NEOPLASMS; RADIOFREQUENCIES; US CONTRAST MEDIUM;

CONTRAST MEDIA;

SONOVUE;

ANGIOGRAPHY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 0033371899     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199911001-00005     Document Type: Conference Paper

References (57)

1. Choi BI, Park JH, Kim BH, Kim SH, Han MC, Kim CW. Small hepatocellular carcinoma: detection with sonography, computed tomography (CT), angiography and lipiodol-CT. Br J Radiol 1989;62:897-903.
2. Matsui O, Itai Y. Diagnosis of primary liver cancer by computed tomography. In: Tobe T, Kameda H, Okudaira M, et al, eds. Primary liver cancer in Japan. Tokyo: Springer-Verlag, 1992: 132.
3. Sheu JC, Sung JL, Chen DS, et al. Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments. Radiology 1984;150:797-802.
4. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR 1990;155:49-54.
5. Clarke MP, Kane RA, Steele G, et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors. Surgery 1989;106:849-55.
6. Gazelle GS, Haaga JR. Hepatic neoplasms: surgically relevant segmental anatomy and imaging techniques. AJR 1992;158:1015-8.
7. Ros PR, Murphy BJ, Buck JL, Olmedilla G, Goodman Z. Encapsulated hepatocellular carcinoma: radiologic findings and pathologic correlations. Gastrointest Radiol 1990;15:233-7.
8. Tanaka S, Kitamura T, Imaoka S, Sasaki Y, Taniguchi H, Ishiguro S. Hepatocellular carcinoma: sonographic and histologic correlation. AJR 1983;140:701-7.
9. Tanaka S, Kitamura T, Ahshima A, et al. Diagnostic accuracy of ultrasonography for hepatocellular carcinoma. Cancer 1986;58: 344-7.
10. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Kojima J, Fujimoto I. Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma. Cancer 1989;63:1313-7.
11. Kudo M, Hirasa M, Takakuwa H, et al. Small hepatocellular carcinomas in chronic liver disease: detection with SPECT. Radiology 1986;159:697-703.
12. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
13. Mathieu D, Guinet C, Bouklia-Hassane A, Vasile N. Hepatic vein involvement in hepatocellular carcinoma. Gastrointest Radiol 1988; 13:55-60.
14. Dodd GD III, Memel DS, Baron RL, Eichner L, Santiguida LA. Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR 1995;165:573-7.
15. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99:694-702.
16. Garbagnati F, Spreafico C, Marchianò A, Salvetti M, Segura C, Piragine G. Staging of hepatocellular carcinoma by ultrasonography, computed tomography, and angiography : the role of CT combined with arterial portography. Gastrointest Radiol 1991;16: 225-8.
17. Miller WJ, Federle MP, Campbell WL. Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplanted patients. AJR 1991;157:303-6.
18. Spreafico C, Marchianò A, Mazzaferro V, et al. Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil. Radiology 1997;203:457-60.
19. Dodd GD III, Miller WJ, Baron RL, et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR 1992;159:727-33.
20. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology 1986;91:198-208.
21. Matsui O, Kadoya M, Kameyama T, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MRI imaging. Radiology 1989;173:123-6.
22. Nino-Murcia M, Ralls PW, Jeffrey RB, Johnson M. Color flow Doppler characterization of focal hepatic lesions. AJR 1992;159: 1195-7.
23. Reinhold C, Hammers L, Taylor CR. Quedens-Case CL, Holland CK, Taylor KJW. Characterization of focal hepatic lesions with duplex sonographic findings in 198 patients. AJR 1995;164:1131-5.
24. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR 1990;154:509-14.
25. Tanaka S, Kitamura T, Fujita M, Kasugai H, Inoue A, Ishiguro S. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 1992;182:161-5.
26. Yasuhara K, Kitamura K, Ohio M, et al. Pulsed Doppler in the diagnosis of small liver tumors. Br J Radiol 1988;61:898-902.
27. Matsui O, Kameyama T, Yoshikawa J, et al. Angiographic diagnosis of hepatocellular carcinoma including CT arteriography and CT arterial portography [in Japanese]. J Med Imaging 1988;8:1289-1300.
28. Choi BI, Han JK, Song IS, et al. Intraoperative sonography of hepatocellular carcinoma : detection of lesions and validity in surgical resection. Gastrointest Radiol 1991;16:329-33.
29. Baron RL, Oliver JH, Dodd GD III, et al. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996;199:505-11.
30. Hollett MD, Jeffrey RB, Nino-Murcia M, et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (less than 1.5 cm) malignant hepatic neoplasms. AJR 1995;164:879-84.
31. van Leeuwen MS, Noordzij J, Feldberg MAM, Hennipman AH, Doornewaard H. Focal liver lesions: characterization with triphasic spiral CT. Radiology 1996;201:327-36.
32. Winter TC III, Takayasu K, Muramatsu Y, et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 1994;192:379-87.
33. Ebara M, Fukuda H, Kojima Y, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999;210:81-8.
34. Kanematsu M, Hoshi H, Murakami T, et al. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR 1997;169:1507-15.
35. Yamashita Y, Fan ZM, Yamamoto H, et al. Spin-echo and dynamic Gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. JMRI 1994;4:83-90.
36. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP. Initial clinical results in 40 patients. Radiology 1992;182:167-74.
37. Manfredi R, Maresca G, Baron RL, et al. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 1999;9:704-10.
38. Carter R, Hemingway D, Pickard R, Poon FW, MacKillop JA, McArdle CS. A prospective study of six methods for detection of hepatic colorectal metastases. Ann Royal Coll Surg Engl 1996;78: 27-30.
39. Cosgrove DO, Bolondi L. Malignant liver disease. In: Cosgrove DO, Meire H, Dewbury K, eds. Abdominal and general ultrasound. Vol 1. Edinburgh, Scotland: Churchill Livingstone, 1993:271-93.
40. Fevery J, Baert AL, Marchal GM, et al. The value of computed tomography, ultrasonography, and peritoneoscopy with biopsy in the detection of liver metastases secondary to gastro-enterological tumors. Acta Gastroenterol Belg 1985;48:105-110.
41. Lundstedt C, Ekberg H, Hederstrom E, et al. Radiologic diagnosis of liver metastases in colorectal carcinoma. Prospective evaluation of the accuracy of angiography, ultrasonography, computed tomography and computed tomographic angiography. Acta Radiol 1987; 28:431-8.
42. Machi J, Isomoto H, Yamashita Y, et al. Intraoperative ultrasonography in screening for liver metastases from colorectal cancer: comparative study accuracy with traditional procedures. Surgery 1987;101:678-84.
43. Schreve RH, Terpstra OT, Ausema L, et al. Detection of liver metastases. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography. Br J Surg 1984;71: 947-9.
44. Kudo M, Tomita S, Tochi H, et al. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR 1992; 158:65-74.
45. Blomley MJK, Albrecht T, Cosgrove DO, Jayaram V, Butler-Barnes J, Eckersley RJ. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998;351:568.
46. Uhlendorf V, Hoffman C. Non-linear acoustic response of coated microbubbles in diagnostic ultrasound. Proceedings of the IEEE International Ultrasonics Symposium. Piscataway, NJ: IEEE 1994; 1559-62.
47. Blomley MJ, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999;210:409-16.
48. Gozzetti G, Mazziotti A. Expectations and possibilities of liver resection in the management of secondary liver tumors. In: Lygidakis NJ, Tytgat GNF, eds. Hepatobiliary and pancreatic malignancies. Diagnosis, medical and surgical management. Stuttgart: Thieme, 1989:183-90.
49. Freeny PC, Marks WM. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT. Radiology 1986;160:613-8.
50. Stark DD, Wittenberg J, Butch RJ, et al. MR detection of hepatic metastases: a randomized, controlled comparison with CT. Radiology 1987;165:399-406.
51. Heiken JP, Weyman PJ, Lee JKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography and MRI. Radiology 1989;171:47-52.
52. Nelson RC. Staging liver tumors for therapeutic intervention: determination of resectability by CT-angiography. In: Ferrucci JT, Stark DD, eds. Liver imaging: current trends and new techniques. Boston: Andover Med Publ, 1990:237-40.
53. Premkumar A, Sanders L, Marincola F, et al. Visceral metastases from melanoma: findings on MR imaging. AJR 1992;158:293-298.
54. Soyer P, Levesque M, Legmann P, et al. Imagerie par resonance magnetique des tumeurs hepatiques malignes de l'adulte. J Radiol 1992;73:219-28.
55. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PIM, Borel Rinkes IHM, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997;203:449-56.
56. Caudana R, Morana G, Pirovano G, et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - preliminary results of phase II clinical application. Radiology 1997;203:513-20.
57. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers. Acad Radiol 1999;6:282-91.